GlaxoSmithKline S.A.E (EGX:BIOC)

GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	317.23	75.47	829.34	585.85	73.57	22.16
Cash & Short-Term Investments	317.23	75.47	829.34	585.85	73.57	22.16
Cash Growth	80.96%	-90.90%	41.56%	696.36%	232.01%	-91.18%
Accounts Receivable	551.13	619.73	685.96	424.68	253.94	269.39
Other Receivables	12.31	50.34	23.89	318.64	408.81	221.5
Receivables	1,685	1,661	1,176	1,165	830.42	641.44
Inventory	1,869	945.21	695.27	485.89	500.45	456.05
Prepaid Expenses	-	-	-	-	17.58	20.46
Other Current Assets	227.35	183.55	164.7	216.65	126.47	143.34
Total Current Assets	4,098	2,865	2,866	2,454	1,548	1,283
Property, Plant & Equipment	653.22	641.17	572.14	548.11	540.21	476.53
Long-Term Investments	-	7.34	6.34	24.45	12.3	21.51
Goodwill	-	-	-	137.65	238.65	238.65
Long-Term Deferred Tax Assets	-	23.33	17.43	-	-	-
Other Long-Term Assets	122.59	115.83	96.48	21.33	85.09	97.2
Total Assets	4,874	3,653	3,558	3,185	2,425	2,117
Accounts Payable	1,755	486.93	524.53	176.8	104.54	49.28
Accrued Expenses	572.87	577.83	524.12	304.51	581.22	522.35
Short-Term Debt	-	-	-	-	118.21	145.73
Current Portion of Leases	45.56	38.28	28.39	17.48	29.52	-
Current Income Taxes Payable	48.56	159.39	97.93	308.57	17.38	1.23
Other Current Liabilities	379.64	313.45	348.98	585.89	161.22	170.56
Total Current Liabilities	2,801	1,576	1,524	1,393	1,012	889.15
Long-Term Leases	35.64	81.2	68.63	52.07	32.24	-
Long-Term Deferred Tax Liabilities	21.76	-	-	11.31	22.46	15.09
Total Liabilities	2,859	1,657	1,593	1,457	1,067	904.25
Common Stock	835.14	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,179	1,160	1,130	892.71	522.24	377.36
Total Common Equity	2,014	1,995	1,965	1,728	1,357	1,213
Minority Interest	0.61	0.6	0.6	0.58	0.58	0.59
Shareholders' Equity	2,015	1,996	1,965	1,728	1,358	1,213
Total Liabilities & Equity	4,874	3,653	3,558	3,185	2,425	2,117
Total Debt	81.2	119.48	97.03	69.55	179.97	145.73
Net Cash (Debt)	236.02	-44.01	732.32	516.3	-106.41	-123.58
Net Cash Growth	444.75%	-	41.84%	-	-	-
Net Cash Per Share	2.83	-0.53	8.77	6.18	-1.27	-1.48
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51	83.51
Working Capital	1,296	1,289	1,342	1,060	536.41	394.3
Book Value Per Share	24.12	23.89	23.53	20.69	16.25	14.52
Tangible Book Value	2,014	1,995	1,965	1,590	1,119	973.85
Tangible Book Value Per Share	24.12	23.89	23.53	19.04	13.40	11.66
Land	-	17.59	17.59	12.65	12.65	12.65
Buildings	-	74.34	83.47	97.81	97.81	97.81
Machinery	-	696.44	668.83	662.18	629.59	571.91
Construction In Progress	140.58	152.54	108.51	88.86	98.67	122.98
Leasehold Improvements	-	24.27	26.81	26.85	42.34	42.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.